Real-time cellular analysis for quantitative detection of functional Clostridium difficile toxin in stool

Expert Review of Molecular Diagnostics

Volumn 14, Issue 3, 2014, Pages 281-291

  Huang, Bin ^a,b   Li, Haijing ^c   Jin, Dazhi ^b,c,d   Stratton, Charles W ^c   Tang, Yi Wei ^b,c,e  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Clostridium difficile; detection; quantification; real time cellular analysis; toxin

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; FECES; LABORATORY DIAGNOSIS; MICROBIOLOGICAL EXAMINATION; MONITORING; PROCEDURES; QUANTITATIVE ASSAY; REAL TIME CELLULAR ANALYSIS;

BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CYTOLOGICAL TECHNIQUES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS;

EID: 84896997306     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2014.900442     Document Type: Article

References (53)

1. Williams OM, Spencer RC. The management of Clostridium difficile infection. Br Med Bull 2009;91:87-110
2. Knetsch CW, Bakker D, de Boer RF, et al. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection. J Clin Microbiol 2011;49(1):227-31
3. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009;7(7): 526-36
4. Wang L, Stewart DB. Increasing hospital costs for Clostridium difficile colitis: type of hospital matters. Surgery 2011;150(4):727-35
5. Johnson S. Clostridium difficile toxins and severe C. difficile infection. J Infect Dis 2012;205(3):353-4
6. Lyras D, OConnor JR, Howarth PM, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458(7242):1176-9
7. Matamouros S, England P, Dupuy B. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 2007;64(5):1274-88
8. Goldenberg SD, Cliff PR, French GL. Laboratory diagnosis of Clostridium difficile infection. J Clin Microbiol 2010;48(8): 3048-9
9. Fenner L, Widmer AF, Goy G, et al. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2008;46(1):328-30
10. Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010;48(2):606-8
11. Ticehurst JR, Aird DZ, Dam LM, et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006;44(3):1145-9
12. Wren MW, Sivapalan M, Kinson R, Shetty NR. Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory. Br J Biomed Sci 2009;66(1):1-5
13. Reller ME, Alcabasa RC, Lema CA, Carroll KC. Comparison of two rapid assays for Clostridium difficile Common antigen and a C difficile toxin A/B assay with the cell culture neutralization assay. Am J Clin Pathol 2010;133(1):107-9
14. Leslie JL, Cohen SH, Solnick JV, Polage CR. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing? Eur J Clin Microbiol Infect Dis 2012;31(12):3295-9
15. Babady NE, Stiles J, Ruggiero P, et al. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 2010;48(12):4519-24
16. Stamper PD, Alcabasa R, Aird D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 2009;47(2):373-8
17. Pancholi P, Kelly C, Raczkowski M, Balada-Llasat JM. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J Clin Microbiol 2012;50(4): 1331-5
18. OHoro JC, Jones A, Sternke M, et al. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc 2012;87(7):643-51
19. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009;15(12):1053-66
20. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010; 51(1):2-7
21. Tenover FC, Novak-Weekley S, Woods CW, et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 2010;48(10):3719-24
22. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-55
23. Brecher SM, Novak-Weekley SM, Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013;57(8):1175-81
24. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013;13(11):936-45
25. Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013; 56(1):67-73
26. Akerlund T, Svenungsson B, Lagergren A, Burman LG. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006;44(2):353-8
27. Wilcox MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 2012;18(Suppl 6):13-20
28. Solly K, Wang X, Xu X, et al. Application of real-time cell electronic sensing (RTCES) technology to cell-based assays. Assay Drug Dev Technol 2004;2(4):363-72
29. Ryder AB, Huang Y, Li H, et al. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol 2010;48(11):4129-34
30. Fang Y, Ye P, Wang X, et al. Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology. J Virol Methods 2011;173(2):251-8
31. Golke A, Cymerys J, Slonska A, et al. The xCELLigence system for real-time and label-free analysis of neuronal and dermal cell response to equine herpesvirus type 1 infection. Pol J Vet Sci 2012;15(1): 151-3
32. Abassi YA, Xi B, Zhang W, et al. Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects. Chem Biol 2009;16(7):712-23
33. Tian D, Zhang W, He J, et al. Novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus. PLoS One 2012;7(2):e31965
34. Huang DY, Mock M, Hagenbuch B, et al. Dynamic cytotoxic response to microcystins using microelectronic sensor arrays. Environ Sci Technol 2009;43(20):7803-9
35. Xing JZ, Zhu L, Gabos S, Xie L. Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol In Vitro 2006;20(6): 995-1004
36. He X, Wang J, Steele J, et al. An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins. J Microbiol Methods 2009;78(1): 97-100
37. Schubert-Unkmeir A, Konrad C, Slanina H, et al. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog 2010;6(4): e1000874
38. Slanina H, Konig A, Claus H, et al. Real-time impedance analysis of host cell response to meningococcal infection. J Microbiol Methods 2011;84(1):101-8
39. Drew CP, Gardner IA, Mayo CE, et al. Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death. Vet Immunol Immunopathol 2010;136(1-2): 108-15
40. Witkowski PT, Schuenadel L, Wiethaus J, et al. Cellular impedance measurement as a new tool for poxvirus titration, antibody neutralization testing and evaluation of antiviral substances. Biochem Biophys Res Commun 2010;401(1):37-41
41. Sharma BN, Li R, Bernhoff E, et al. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res 2011;92(1):115-23
42. Fonteh PN, Keter FK, Meyer D. New bis (thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails. J Inorg Biochem 2011;105(9):1173-80
43. Fender P, Hall K, Schoehn G, Blair GE. Impact of human adenovirus type 3 dodecahedron on host cells and its potential role in viral infection. J Virol 2012;86(9):5380-5
44. Huang B, Jin D, Zhang J, et al. Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J Clin Microbiol 2014;54(4):1105-11
45. Atienza JM, Zhu J, Wang X, et al. Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays. J Biomol Screen 2005;10(8):795-805
46. Zidaric V, Kevorkijan BK, Oresic N, et al. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory. J Med Microbiol 2011;60(Pt 8):1131-6
47. Wren MW, Kinson R, Sivapalan M, et al. Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm. Br J Biomed Sci 2009;66(4):175-9
48. Bamber AI, Fitzsimmons K, Cunniffe JG, et al. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification. Br J Biomed Sci 2012;69(3):112-18
49. Stamper PD, Babiker W, Alcabasa R, et al. Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool specimens. J Clin Microbiol 2009; 47(12):3846-50
50. Novak-Weekley SM, Marlowe EM, Miller JM, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010; 48(3):889-93
51. Buchan BW, Mackey TL, Daly JA, et al. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J Clin Microbiol 2012;50(12):3932-6
52. Dunbar SA, Zhang H, Tang YW. Advanced techniques for detection and identification of microbial agents of gastroenteritis. Clin Lab Med 2013;33(3):527-52
53. Jin D, Luo Y, Zheng M, et al. Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring. J Clin Microbiol 2013;51(12): 3968-74